Medicare Prescription Drug Cost Containment Act of 2004

Summary

Medicare Prescription Drug Cost Containment Act of 2004 - Directs the Secretary of Health and Human Services, on the same date on which the President submits a budget to Congress, to submit to Congress a determination as to whether there is projected to be excess general revenue Medicare prescription drug funding for the fiscal year for which the budget is submitted, and if there is an affirmative determination it shall be treated as a Medicare part D (Voluntary Prescription Drug Benefit Program) funding warning in the fiscal year beginning on October 1 of the year in which the determination is submitted to Congress. Amends Federal money and finance law, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to direct the President to submit to Congress proposed legislation to respond to such a Medicare part D funding warning made in a year within the 15-day period beginning on the date of the budget submission to Congress for the succeeding year. Provides that such amendment shall not apply if, during the year in which the warning is made, legislation is enacted which eliminates excess general revenue Medicare funding for the period beginning with the fiscal year for which the determination is made and ending on September 30, 2013, as certified by the Board of Trustees of the Federal Supplementary Medical Insurance Trust Fund not later than 30 days after the enactment of such legislation. Expresses the sense of Congress that legislation submitted pursuant to such amendment in a year should be designed to eliminate excess general revenue Medicare funding for the period that begins with the fiscal year for which the determination is made and ends on September 30, 2013. Sets out the special procedures for House and Senate consideration of the President's legislative proposal in response to such warning.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 26 February 2004

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 26 February 2004

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 26 February 2004

   Introduced

   Introduced in House

   Source: IntroReferral

4. 26 February 2004

   Introduced

   Introduced in House

   Source: IntroReferral

5. 5 March 2004

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

6. 11 March 2004

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 26 February 2004 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 26 February 2004

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 26 February 2004

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 26 February 2004

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Sen. Flake, Jeff [R-AZ] · R · Sponsor
• Rep. Pence, Mike [R-IN-6] · R · Sponsor
• Rep. Smith, Nick [R-MI-7] · R · Sponsor
• Rep. King, Steve [R-IA-4] · R · Sponsor
• Rep. Akin, W. Todd [R-MO-2] · R · Sponsor
• Rep. Tancredo, Thomas G. [R-CO-6] · R · Sponsor
• Rep. Norwood, Charles W. [R-GA-9] · R · Sponsor
• Rep. Jones, Walter B., Jr. [R-NC-3] · R · Sponsor
• Rep. Bartlett, Roscoe G. [R-MD-6] · R · Sponsor
• Rep. Miller, Jeff [R-FL-1] · R · Sponsor
• Rep. Franks, Trent [R-AZ-8] · R · Sponsor
• Rep. Brady, Kevin [R-TX-8] · R · Sponsor
• Rep. Hensarling, Jeb [R-TX-5] · R · Sponsor
• Rep. Musgrave, Marilyn N. [R-CO-4] · R · Sponsor
• Rep. Barrett, J. Gresham [R-SC-3] · R · Sponsor
• Sen. DeMint, Jim [R-SC] · R · Sponsor
• Rep. Gutknecht, Gil [R-MN-1] · R · Sponsor
• Rep. Feeney, Tom [R-FL-24] · R · Sponsor
• Rep. Paul, Ron [R-TX-14] · R · Cosponsor
• Rep. Duncan, John J., Jr. [R-TN-2] · R · Cosponsor
• Rep. Garrett, Scott [R-NJ-5] · R · Cosponsor
• Rep. Burton, Dan [R-IN-5] · R · Cosponsor
• Rep. Brown-Waite, Ginny [R-FL-5] · R · Cosponsor
• · hsif00 · Standing
• · hswm00 · Standing
• · hsru00 · Standing

Related records

• related to ← Medicare Prescription Drug Cost Containment Act of 2004